Drug Search Results
More Filters [+]

Fluocortolone

Alternative Names: fluocortolone
Latest Update: 2023-11-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: GR Modulator

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | Brazil | Bulgaria | Chile | Croatia | Denmark | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Italy | Latvia | Lithuania | Malta | Morocco | New Zealand | Pakistan | Peru | Portugal | Romania | Russia | Slovakia | Slovenia | Spain | Sweden | Taiwan | Thailand | Turkey | Ukraine | United Kingdom | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: ISTITUTO NAZIONALE PER LA CURA TUMORI
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Fluocortolone

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Breast Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Calendula versus placebo/cortisone in prevention of radiotherapy-induced erythema

P2

Active, not recruiting

Breast Cancer

2009-07-18

Recent News Events